The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tiuvina N.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Pervogo Moskovskogo gosudarstvennogo universiteta im. I.M. Sechenova, Moskva

Stolyarova A.E.

Sechenov First Moscow State Medical University, Moscow, Russia

Smirnova V.N.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Pervogo Moskovskogo gosudarstvennogo universiteta im. I.M. Sechenova, Moskva

Bipolar affective disorder: gender differences in the course and treatment

Authors:

Tiuvina N.A., Stolyarova A.E., Smirnova V.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(12): 162‑169

DOI: 10.17116/jnevro2019119121162

Views: 21868

Downloaded: 669

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Tiuvina NA, Stolyarova AE, Smirnova VN. Bipolar affective disorder: gender differences in the course and treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(12):162‑169. (In Russ.)
https://doi.org/10.17116/jnevro2019119121162

 
МСФ на ЯМ
Close metadata
Recommended articles:
Psychopharmacotherapy of mixed affe­ctive states in bipo­lar diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(2):103-108
The asso­ciation of poly­morphisms of the sero­tonin transporter gene SLC6A4 with depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(2):135-139
The effect of inso­mnia on mild cognitive impairment in patients with vascular risks: resu­lts of a three-year longitudinal study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):30-36
A perspective on the application of CRISPR/CAS9 genome editing system to study of mole­cular-genetic basis of mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):27-33
Vali­dation of screening method based on EEG analysis for the risk asse­ssment of psychiatric and beha­vioral diso­rders: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):88-96
A clinical case of the new-onset bipo­lar affe­ctive diso­rder in the postcovid period. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):125-129
Atypical anti­psychotics in the treatment of depression in affe­ctive diso­rders and schi­zophrenia (using the aripiprazole model). S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):36-42
Pathogenetic basis of modern approaches to the therapy of sleep diso­rders in the clinic of depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):69-74
Features of the clinical picture of affe­ctive diso­rders in women during the meno­pausal transition and early postmenopause. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):75-79
Reproductive atti­tudes of young people: the regional study. Russian Journal of Preventive Medi­cine. 2024;(4):74-81

Bipolar affective disorder (BAD) according to the latest international classifications (ICD-10, DSM-5) is recognized as its own disease, characterized by episodes of mania (or hypomania), hyperthymic personality and (or) a genetic predisposition to BAR in contrast to recurrent depressive disorder (RD). The history of development and classification of manic depressive disorder (MDD), difficulties of differential diagnosis between BAD and RD are presented in this literature review. It considers the clinical features of the course of BAR in men and women and also gender-specific therapy. Gender differences in the clinical picture, course and treatment of BAD are discussed. Attention is drawn to the differences in effectiveness and tolerability of antidepressants in men and women. It is concluded that identifying the gender particularities is important for treatment and prevention optimization.

Keywords:

bipolar affective disorder
recurrent depressive disorder
depression
gender differences
antidepressants

Authors:

Tiuvina N.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Pervogo Moskovskogo gosudarstvennogo universiteta im. I.M. Sechenova, Moskva

Stolyarova A.E.

Sechenov First Moscow State Medical University, Moscow, Russia

Smirnova V.N.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Pervogo Moskovskogo gosudarstvennogo universiteta im. I.M. Sechenova, Moskva

List of references:

  1. Healy D. Mania: a short history of bipolar disorder. Johns Hopkins University Press. 2011;133.
  2. Bleuler E. Handbook of psychiatry (1920). M.: Izdatelstvo nezavisimoy psihiatricheskoy assotsiatsii; 1993. (In Russ.)
  3. Tyuvina NA, Smirnova VN. A comparative evaluation of the efficacy of valdoxan (agomelatine) in recurrent depression and bipolar affective disorder. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2012;11:53-60. (In Russ.)
  4. Leonhard K. Classification of endogenous psychoses and and their Differentiated Etiology. M.: Prakticheskaya meditsina; 2010. (In Russ.)
  5. Angst J, Marneros A. Bipolarity from ancient to modern times: conception, birth and rebirth. J Affect Disord. 2001;67:3-19. https://doi.org/10.1016/S0165-0327(01)00429-3
  6. Akiskal HS. Dysthymia and cyclothymia in psychiatric practice a century after Kraepelin. J Affect Disord. 2001;62:17-31. https://doi.org/10.1016/s0165-0327(00)00347-5
  7. Mosolov SN. Bipolar affective disorder: diagnosis and therapy. M.: MEDpress-inform; 2008. (In Russ.)
  8. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. American Psychiatric Publishing. 2013.
  9. Dmitreeva TB, Krasnov VN, Neznanov NG, Semke VYa, Tiganov AS. Psychiatry. National guidelines. M.: GEOTAR-Media; 2009. (In Russ.)
  10. Akiskal HS, Khani MK, Scott-Strauss A. Cyclothymic temperamental disorders. Psychiatry Clin North Am. 1979;2:527-554.
  11. Levitt AJ, Joffe RT, Ennis J, MacDonald C, Kutcher SP. The prevalence of cyclothymia in borderline personality disorder. J Clin Psychiatry. 1990;51:335-339.
  12. Tischler GL. Diagnosis and classification in psychiatry: A critical appraisal of DSM-III. Cambridge University Press. 1987;3-31.
  13. World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death. Geneva, Switzerland: WHO; 1990.
  14. Suppes T, Kelly DI, Perla JM. Challenges in the management of bipolar depression. J Clin Psychiatry. 2005;66(5):11-16.
  15. Allilaire JF, Hantouche EG, Sechter D, Bourgeois ML, Azorin JM, Lancrenon S, Chatenet-Duchene L, Akiskal HS. Frequence et aspects cliniques du trouble bipolaire II dans une etude multicentrique francaise: EPIDEP. Encephale. 2001;27:149-158.
  16. Vieta E, Colom F. Psychoeducation manual for bipolar disorder. Cambridge University Press. 2006;225. https://doi.org/10.1017/CBO9780511543685
  17. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime cooccurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54(4):313-321.
  18. Angst J, Sellaro R, Stassen HH, Gamma A. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord. 2005;84:149-157. https://doi.org/10.1016/S0165-0327(03)00195-2
  19. Tyuvina NA, Smirnova VN. Bipolar affective disorders: the specific features of the course and maintenance pharmacotherapy. Nevrologiya, Neiropsikhiatriya, Psikhosomatika. 2013;5(1):87-95. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2406
  20. Akzhigitov RG, Yakovlev AYu. To the question about diagnosis of dipolar disorders. Obozrenie Psihiatrii i Med Psihologii. 2011;1:41-45. (In Russ.)
  21. Joffe RT, MacQueen GM, Marriott M, Young LT. A prospective, longitudinal study of percentage of time spent ill in patients with bipolar 1 or bipolar 2 disorders. Bipolar Disord. 2004;6:62-66.
  22. Marneros A, Akiskal HS. The overlap of affective and schizophrenic spectra. Cambridge University Press. 2007;299. https://doi.org/10.1192/bjp.191.4.366
  23. Frye MA, Altshuler LL, McElroy SL, Suppes T, Keck PE, Denicoff K, Nolen WA, Kupka R, Leverich GS, Pollio C, Grunze H, Walden J, Post RM. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry. 2003;160(5):883-889. https://doi.org/10.1176/appi.ajp.160.5.883
  24. Frank E, Kupfer DJ, Thase ME, Mallinger AG, Swartz HA, Fagiolini AM, Grochocinski V, Houck P, Scott J, Thompson W, Monk T. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry. 2005;62(9):996-1004. https://doi.org/10.1001/archpsyc.62.9.996
  25. Akiskal HS, Tohen M. Bipolar psychopharmacotherapy: caring for the patient. John Wiley & Sons. 2006;399.
  26. Kessler R, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627. https://doi.org/10.1001/archpsyc.62.6.593
  27. Petrova NN. To the question about bipolar affective and anxiety disorders comorbidity. Psihiatriya, Psihoterapiya i Klinicheskaya Psihologiya. 2016;2:114-121. (In Russ.)
  28. World Health Organization. The World Health Report 2001 — Mental Health: New Understanding, New Hope. Geneva, Switzerland: WHO; 2001.
  29. Tsuang MT, Woolson RF. Excess mortality in schizophrenia and affective disorders. Do suicides and accidental deaths solely account for this excess? Arch Gen Psychiatry. 1978;35:1181-1185.
  30. Kolyagin VV. Bipolar affective disorder. Irkutsk: RIO IGMAPO — filial FGBOU DPO RMANPO Minzdrava Rossii; 2017. (In Russ.)
  31. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The national Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31(4):281-294.
  32. Papadopulos TF. Acute endogenous psychoses (psychopathology and classification). M.: Medicina; 1975. (In Russ.)
  33. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS. Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry. 1995;152:385-390. https://doi.org/10.1176/ajp.152.3.385
  34. Roy-Byrne P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatrica Scandinavica. 1985;317:1-34.
  35. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. American Psychiatric Publishing. 1994.
  36. Smulevich AB. Depressions and comorbidity disorders. M. 1997. (In Russ.)
  37. Agosti V, Stewart JW. Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression. International Clinical Psychopharmacology. 2007;22(5):309-311. https://doi.org/10.1097/YIC.0b013e3280c28410
  38. Stephen M. Stahl. Essential psychopharmacology: neuroscientific basis and practical applications. Cambridge University Press. 2000.
  39. Kupfer DJ, Frank E, Grochocinski VJ, Cluss PA, Houck PR, Stapf DA. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry. 2002;63(2):120-125.
  40. Arnold LM. Gender differences in bipolar disorder. Psychiatr Clin N Am. 2003;26(3):595-620.
  41. Kawa I, Carter JD, Joyce PR, Doughty CJ, Frampton CM, Wells JE, Walsh AE, Olds RJ. Gender differences in bipolar disorder: age at onset, course, comorbidity, and symptom presentation. Bipolar Disord. 2005;7(2):119-125. https://doi.org/10.1111/j.1399-5618.2004.00180.x
  42. Nivoli AM, Pacchiarotti I, Rosa AR, Popovic D, Murru A, Valenti M, Bonnin CM, Grande I, Sanchez-Moreno J, Vieta E, Colom F. Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J Affect Disord. 2011;133(3):443-449. https://doi.org/10.1016/j.jad.2011.04.055
  43. Tyuvina NA. The differential diagnosis and treatment of depressive disorders in menopausal women. Nevrologiya, Nejropsihiatriya, Psihosomatika. 2011;2:66-71. (In Russ.)
  44. Payne JL, Roy PS, Murphy-Eberenz K, Weismann MM, Swartz KL, McInnis MG, Nwulia E, Mondimore FM, MacKinnon DF, Miller EB, Nurnberger JI, Levinson DF, DePaulo JR Jr, Potash JB. Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. J Affect Disord. 2007;99:221-229. https://doi.org/10.1016/j.jad.2006.08.013
  45. Sharma V, Burt VK, Ritchie HL. Bipolar II postpartum depression: detection, diagnosis and treatment. Am J Psychiatr. 2009;166(11):1217-1221. https://doi.org/10.1176/appi.ajp.2009.08121902
  46. Marangell LB. Current issues: women and bipolar disorder. Dialogues Clin Neurosci. 2008;10(2):229-238.
  47. Judd LL, Akiskal HS, Schlettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003;60:261-269. https://doi.org/10.1001/archpsyc.60.3.261
  48. Judd LL, Akiskal HS, Schlettler PJ, Endicott J, Maser JD, Solomon DA, Leon AC, Rice JA, Keller MB. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59:530. https://doi.org/10.1001/archpsyc.59.6.530
  49. Grunze H. The clinical side of bipolar disorders. Pharmacopsychiatry. 2011;44(1):43-48. https://doi.org/10.1055/s-0031-1275281
  50. Tyuvina NA, Korobkova IG. Comparative clinical characteristics of depression in bipolar affective disorders types I and II. Nevrologiya, Neiropsikhiatriya, Psikhosomatika. 2016;8(1):22-28. (In Russ.) https://doi.org/10.14412/2074-2711-2016-1-22-28
  51. Young M, Scheftner W, Fawcett J, Klerman GL. Gender differences in the clinical features of unipolar major depressive disorders. J Nerv Ment Dis. 1990;178:200-203. https://doi.org/10.1097/00005053-199003000-00008
  52. Avedisova AS, Marachev MP. Clinical typology of atypical depression in bipolar and unipolar affective disorders. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2012;112(3):18-23. (In Russ.)
  53. Patel RS, Virani S, Saeed H, Nimmagadda S, Talukdar J, Youssef NA. Gender differences and comorbidities in US adults with bipolar disorder. Brain Sciences. 2018;8(9):168. https://doi.org/10.3390/brainsci8090168
  54. Coryell W, Solomon DA, Fiedorowicz JG, Endicott J, Schettler P, Judd L. Anxiety and outcome in bipolar disorder. Am J Psychiatry. 2009;166:1238-1243. https://doi.org/10.1176/appi.ajp.2009.09020218
  55. Mantere O, Isometsa E, Ketokivi M, Kiviruusu O, Suominen K, Valtonen HM, Arvilommi P, Leppamaki S. Prospective latent analyses study of psychiatric comorbidity of DSM-IV bipolar I and II disorders. Bipolar Disord. 2010;12:271-284. https://doi.org/10.1111/j.1399-5618.2010.00810.x
  56. Ivanets NN, Tyuvina NA, Voronina EO, Balabanova VV. Comparative evaluation of depressive disorders in women and men. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2018;118(11):15-19. (In Russ.) https://doi.org/10.17116/jnevro201811811115
  57. Van Pragg H. Serotonin dysfunction and aggression control. Psychol Med. 1996;21:15-19.
  58. Stepanov IL, Goryacheva EK. Gender differences of depression and social functioning among patients with recurrent or bipolar disorder. Social’naya i Klinicheskaya Psihiatriya. 2012;22(1):38-43. (In Russ.)
  59. Frances A, Docherty J, Kahn D. The expert consensus guideline series: Treatment of bipolar disorder. J Clin Psychiatry. 1996;57(1):88.
  60. Frances AJ, Kahn DA, Carpenter D, Docherty JP, Donovan SL. The expert consensus guidelines for treating depression in bipolar disorder. J Clin Psychiatry. 1998;59(4):73-79.
  61. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2003;17:149-173. https://doi.org/10.1177/0269881116636545
  62. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorder. 2009;11:225-255.
  63. Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS. Treatment guidelines for bipolar disorder: A critical review. J Affect Disord. 2005;86:1-10. https://doi.org/10.1016/j.jad.2005.01.004
  64. Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine in the prevention of affective episodes. Arch Gen Psychiatry. 1973;29:420-425. https://doi.org/10.1001/archpsyc.1973.04200030104017
  65. Tyuvina NA, Korobkova IG. Therapy for depression in bipolar affective disorder. Nevrologiya, Neiropsikhiatriya, Psikhosomatika. 2016;8(2):36-43. (In Russ.) https://doi.org/10.14412/2074-2711-2016-2-36-43
  66. Montgomery SA. The advantages of paroxetine in different subgroups of depression. Int Clin Psychopharmacol. 1992;6(4):91-100.
  67. Altshuler L, Suppes T, Black D, Nolen WA, Keck PE, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G, Denicoff K, Luckenbaugh D, Post R. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry. 2003;160:1252-1262. https://doi.org/10.1176/appi.ajp.160.7.1252
  68. Kostyukova EG, Mosolov SN. Modern approaches to the diagnosis, treatment and prevention of bipolar depression. Social’naya i Klinicheskaya Psihiatriya. 2003;4:106-114. (In Russ.)
  69. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind, placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry. 1999;60:79-88.
  70. McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH. Topiramate versus bupropion SR when added to mood-stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord. 2002;4(3):207-213.
  71. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry. 2000;157(1):124-126. https://doi.org/10.1176/ajp.157.1.124
  72. Doree JP, Des Rosiers J, Lew V, Gendron A, Elie R, Stip E, Tourjman SV. Quetiapine augmentation of treatment-resistant depression: a comparison with lithium. Curr Med Res Opin. 2007;23(2):333-341. https://doi.org/10.1185/030079906X162809
  73. Haustova EA. Modern strategy of diagnosis and treatment of depression. Liki Ukrainy Kardionevrologiya. 2012;9(165):48-52. (In Russ.)
  74. Sachs GS, Koslov CL, Ghaemi SN. The treatment of bipolar depression. Bipolar Disord. 2000;2:256-260.
  75. Hamilton JA, Jensvold MF, et al. Psychopharmacology and women: sex, gender and hormones. American Psychiatric Press. 1996;11-42.
  76. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry. 2000;157:1445-1452. https://doi.org/10.1176/appi.ajp.157.9.1445
  77. Davidson J, Pelton S. Forms of atypical depression and their response to antidepressant drugs. Psychiatry Research. 1986;17:87-95.
  78. Tyuvina NA, Balabanova VV, Voronina EO. Gender differences of the treatment of depression among women. Psihiatriya i Psihofarmakoterapiya. 2017;19(5):25-31. (In Russ.) https://doi.org/10.17116/jnevro201811811115
  79. Entsuah R, Huang H, Thase ME. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry. 2001;62:869-877.
  80. Kasper S, Corruble E, Hale A, Lemoine P, Montgomery SA, Quera-Salva MA. Antidepressant efficacy of agomelatin versus SSRI/SNRI: results from a pooled analysis of bead-to-bead studies without a placebo control. Int Clin Psychopharmacol. 2013;28:12-19. https://doi.org/10.1097/YIC.0b013e328359768e
  81. Taylor D, Sparshatt A, Varma S, Olofinjana O. Antidepressant efficacy of agomelatin: meta-analysis of published and unpublished studies. BMJ. 2014;348. https://doi.org/10.1136/bmj.g1888
  82. Khoo AL, Zhou HJ, Teng M, Lin L, Zhao YJ, Soh LB, Mok YM, Lim BP, Gwee KP. Network meta-analysis and cost-effectiveness analysis of new generation antidepressants. CNS Drugs. 2015;29(8):695-712. https://doi.org/10.1007/s40263-015-0267-6
  83. Kennedy SH. Treating each and every depressed patient. J Psychopharmacol. 2008;22(7):19-23. https://doi.org/10.1177/0269881108093270

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.